These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1640734)

  • 1. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal and leukemic bone marrow progenitor cells.
    Bhalla K; Bullock G; Lutzky J; Holladay C; Ibrado AM; Jasiok M; Singh S
    Leukemia; 1992 Aug; 6(8):814-9. PubMed ID: 1640734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bullock G; Tang C; Tourkina E; Ibrado AM; Lutzky J; Huang Y; Mahoney ME; Bhalla K
    Exp Hematol; 1993 Dec; 21(13):1640-7. PubMed ID: 8243566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interleukin 3 and interleukin 6 in the protection from 4-hydroperoxycyclophosphamide and the proliferation of early human hematopoietic progenitor cells.
    Moreb J; Zucali JR; Weiner RS
    Exp Hematol; 1989 Nov; 17(10):1022-7. PubMed ID: 2806435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
    Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
    Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
    Bhalla K; Holladay C; Arlin Z; Grant S; Ibrado AM; Jasiok M
    Blood; 1991 Nov; 78(10):2674-9. PubMed ID: 1824260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
    J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
    Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
    Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
    Lemoli RM; Strife A; Clarkson BD; Haley JD; Gulati SC
    Exp Hematol; 1992 Dec; 20(11):1252-6. PubMed ID: 1493854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
    Chang TT; Gulati SC; Chou TC; Vega R; Gandola L; Ibrahim SM; Yopp J; Colvin M; Clarkson BD
    Cancer Res; 1985 Jun; 45(6):2434-9. PubMed ID: 3857119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta 2/interleukin-6 and interleukin-3 synergize in stimulating proliferation of human early hematopoietic progenitor cells.
    Michalevicz R; Lifshitz D; Revel M
    Scanning Microsc; 1989 Dec; 3(4):1143-9; discussion 1149-50. PubMed ID: 2633333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM; Yeager AM
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.